Skip to main content
. 2020 Jul 30;106(7):1892–1901. doi: 10.3324/haematol.2020.253781

Figure 3.

Figure 3.

Comparison of clinical indicators changes before and 1 week after ruxolitinib therapy in the complete response group (CR, n=8) and non-CR group (n=4) respectively. For patients who discontinued ruxolitinib (RUX) within 7 days, the last known values were used as the week-1 laboratory results. For statistical analysis, the paired sample Wilcoxon signed rank test was applied.